TNF-related apoptosis-inducing ligand (TRAIL) is a protein that can induce the apoptotic death of many types of tumor cells, leading many researchers to attempt to develop TRAIL-receptor agonists as a form of anti-cancer therapy [7, 8]. This evidence concerns the gene TNFSF10 and cancer.